Genomictree Inc. (KOSDAQ:228760)
South Korea · Delayed Price · Currency is KRW 20,150
-600 (-2.89%)
Oct 10, 2025, 3:30 PM KST
Genomictree Market Cap
Genomictree has a market cap or net worth of 483.94 billion as of October 10, 2025. Its market cap has increased by 23.80% in one year.
Market Cap
483.94B
Enterprise Value
400.13B
Revenue
3.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
20,150.00
Market Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 483.94B, an increase of 720.26%. That is a compound annual growth rate of 28.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 483.94B | -1.36% |
| Dec 30, 2024 | 490.60B | 0.78% |
| Dec 28, 2023 | 486.82B | 168.25% |
| Dec 29, 2022 | 181.48B | -32.87% |
| Dec 30, 2021 | 270.36B | -7.66% |
| Dec 30, 2020 | 292.80B | -37.53% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.17T |
| Celltrion | 38.24T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,136.75B |
| Peptron | 6,866.96B |
| PharmaResearch | 5,631.19B |
| LigaChem Biosciences | 5,545.53B |